Speaker
Mark Gooding
Mark completed a DPhil in Medical Image Analysis at University of Oxford in 2004. Subsequently he held academic post-doctoral research positions in both academia and the NHS, largely focused around women’s health. In 2009, he joined Mirada Medical Ltd, motivated by a desire to see technical innovation translated into clinical practice. He has worked on a broad spectrum of clinical applications, developing algorithms for both diagnostic and therapeutic purposes, and in a broad variety of roles. As Chief Scientific Officer at Mirada, Mark led the team that developed the first deep-learning based autocontouring software for radiation oncology that was cleared for clinical use. In 2022, he founded Inpictura to bring technical innovations to the clinic by fostering collaboration between industry, academia and the clinics. In addition to his commercial work, Dr Gooding was recently appointed as an Honorary Senior Research Fellow at the University of Manchester working with the Radiotherapy Related Research Group.
Mark’s “happy place” when at work is somewhere between academia and industry (technology readiness levels 3-8). He loves researching solutions to challenging problems but is passionate about getting those solutions to the clinical end-user.
More Information:
Talks at this conference:
13:20 | An ambitious vision for the future of AI in Radiotherapy Live |
14:00 | Panel Discussion Live |